Improve people's lives

That is our purpose and the principle that has guided us since our foundation. We care for the health of people and we do it with passion and commitment

DISCOVER WHO WE ARE

Discover Our Expertise

Learn more about how we are making a difference in the healthcare industry

Pharma CDMO Services

Pharma

CDMO

Who we are

Discover our purpose and commitment by watching our corporate video

Stay in the loop with the latest news

20/03/2026

ESTEVE CDMO PLANS ADDITIONAL SPRAY DRYERS AND CONTAINMENT IN GIRONA, SPAIN, AND LAUNCHES NEW BRAND

ESTEVE CDMO, the global pure-play CDMO specializing in high-quality small-molecule APIs and advanced pharmaceutical intermediates, today announced that it would add to its plans for the buildout of a new production unit at its facility in Celrà, and launch its new brand identity at DCAT Week in New York.

06/03/2026

ESTEVE CDMO COMMENCES $15.5 MILLION EXPANSION OF CHICAGO SMALL MOLECULE API FACILITY

ESTEVE CDMO, the global pure-play CDMO specializing in high-quality small-molecule APIs and pharmaceutical intermediates, today announced that it had commenced a $15.5-million investment to enhance production capabilities and associated space at its newly acquired North American facility in Morton Grove, Illinois.

21/01/2026

ESTEVE BECOMES A B CORP COMPANY FOR ITS SOCIAL COMMITMENT, ENVIRONMENTAL AWARENESS, AND TRANSPARENCY

The company joins a global movement of more than 10,000 corporations that drives businesses to generate positive impact beyond financial goals.

13/01/2026

ESTEVE TO ACQUIRE TERSERA THERAPEUTICS’ INFUSION SPECIALTY THERAPIES BUSINESS UNIT, EXPANDING U.S. PRESENCE

ESTEVE and TerSera Therapeutics LLC announced today that they have entered into an agreement in which ESTEVE will acquire TerSera's Infusion Specialty Therapies Business Unit (IST). This strategic acquisition enables ESTEVE to expand its U.S. presence, with two highly specialized on-market assets and a dedicated team of sales, marketing and medical professionals.